Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by WinterCon Aug 19, 2016 8:11pm
129 Views
Post# 25160314

RE:RE:Like I said 2.10-2.20 couple weeks..

RE:RE:Like I said 2.10-2.20 couple weeks..
Kcirnek wrote: You coudln't be more wrong.

Aphria is under priced compared to the competition. Fastest to turn a profit, making the right moves, best management, and lowest cost.

The old support was $2.20, new support is $2.30. 

New resistance is $2.40.

It's not going to $2.10 to $2.20


Its hard to place a value on a speculative stock and compare it between compeition when they are indeed already valued multiple of it's earnings. Is it under priced compared to the competition? Not really, and all of the profits, management and lowest cost were put into consideration in its year-to-year growth. Aphria had the higest gain in the stock price over any competition. All COMA stocks are currently over valued. This does not mean that the stock will come down like JTDouble mentioned. The amount of potential it has covers for all these factors.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse